Invesco Pharmaceuticals 

$107.22
16
+$1.96+1.86% Monday 20:59

Statistics

Day High
107.22
Day Low
105.66
52W High
108.4
52W Low
72.25
Volume
79,937
Avg. Volume
37,903
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.95%
Dividend
1.02

Upcoming

Dividends

0.95%Dividend Yield
Dec 25
$0.25
Sep 25
$0.24
Jun 25
$0.27
Mar 25
$0.27
Dec 24
$0.22
10Y Growth
7.17%
5Y Growth
9.15%
3Y Growth
9.88%
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PJP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares U.S. Pharmaceuticals
IHE
Mkt Cap0
IHE is the iShares U.S. Pharmaceuticals ETF, directly competing with PJP by investing in U.S. pharmaceutical companies.
State Street SPDR S&P Pharmaceuticals
XPH
Mkt Cap0
XPH is the SPDR S&P Pharmaceuticals ETF, offering similar exposure to the pharmaceutical sector as PJP, making it a direct competitor.
Invesco Pharmaceuticals
PJP
Mkt Cap0
PJP is the Invesco Pharmaceuticals ETF, directly competing with itself through different share classes or investment strategies within the pharmaceutical sector.
Fidelity MSCI Health Care Index
FHLC
Mkt Cap0
FHLC is the Fidelity MSCI Health Care Index ETF, competing by covering a broad range of healthcare stocks, including pharmaceuticals.
Vanguard Health Care
VHT
Mkt Cap0
VHT is the Vanguard Health Care ETF, which includes pharmaceutical companies in its portfolio, competing for the same investment dollars.
State Street Health Care Select Sector SPDR
XLV
Mkt Cap0
XLV is the Health Care Select Sector SPDR Fund, competing by offering exposure to healthcare, including pharmaceuticals, in the S&P 500.
VanEck Biotech
BBH
Mkt Cap0
BBH is the VanEck Vectors Biotech ETF, competing by investing in biotech which overlaps with pharmaceuticals, offering an alternative within the sector.
iShares Biotechnology
IBB
Mkt Cap0
IBB is the iShares Biotechnology ETF, a competitor by focusing on biotechnology, a sub-sector of pharmaceuticals, attracting similar investors.
Johnson & Johnson
JNJ
Mkt Cap455.04B
JNJ, Johnson & Johnson, competes as a major pharmaceutical company within many ETFs' portfolios, including PJP, representing direct industry competition.
Pfizer
PFE
Mkt Cap140.15B
PFE, Pfizer Inc, is a direct competitor as a leading pharmaceutical company, influencing the performance of pharmaceutical-focused ETFs like PJP.

About

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US46137V6627

Listings

0 Comments

Share your thoughts

FAQ

What is Invesco Pharmaceuticals stock price today?
The current price of PJP is $107.22 USD — it has increased by +1.86% in the past 24 hours. Watch Invesco Pharmaceuticals stock price performance more closely on the chart.
What is Invesco Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Invesco Pharmaceuticals stocks are traded under the ticker PJP.
Is Invesco Pharmaceuticals stock price growing?
PJP stock has risen by +1.05% compared to the previous week, the month change is a +2.71% rise, over the last year Invesco Pharmaceuticals has showed a +24.86% increase.
Does Invesco Pharmaceuticals pay dividends?
Yes, PJP dividends are paid quarterly. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 0.95%.
When did Invesco Pharmaceuticals complete a stock split?
Invesco Pharmaceuticals has not had any recent stock splits.